{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T15:43:54Z","timestamp":1782920634879,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jbspin.2026.106053","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:49:04Z","timestamp":1773938944000},"page":"106053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["AA amyloidosis in inflammatory joint diseases in the era of biological therapies: Prevalence, manifestations, management and evolution"],"prefix":"10.1016","volume":"93","author":[{"given":"Anna","family":"Raymond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binta","family":"Savadogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rim","family":"Bourguiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeddine","family":"Dellal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Buob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9a","family":"Savey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Grateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Assaraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Cez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Antoine","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Sellam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Fautrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5244-7881","authenticated-orcid":false,"given":"St\u00e9phane","family":"Mitrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2026.106053_bib0200","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","article-title":"Natural history and outcome in systemic AA amyloidosis","volume":"356","author":"Lachmann","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2026.106053_bib0205","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/rheumatology\/38.6.499","article-title":"Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland","volume":"38","author":"Myllykangas-Luosujarvi","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2026.106053_bib0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jbspin.2008.08.009","article-title":"Prevalence of subclinical amyloidosis in Tunisian patients with rheumatoid arthritis","volume":"76","author":"Younes","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2026.106053_bib0215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejim.2020.08.012","article-title":"Cause of death and risk factors for mortality in AA amyloidosis: A French retrospective study","volume":"82","author":"Terr\u00e9","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jbspin.2026.106053_bib0220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.revmed.2022.12.004","article-title":"French practical guidelines for the diagnosis and management of AA amyloidosis","volume":"44","author":"Georgin-Lavialle","year":"2023","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jbspin.2026.106053_bib0225","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2169\/internalmedicine.42.800","article-title":"Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis","volume":"42","author":"Ishii","year":"2003","journal-title":"Intern Med"},{"key":"10.1016\/j.jbspin.2026.106053_bib0230","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00296-012-2646-3","article-title":"Secondary amyloidosis in ankylosing spondylitis","volume":"33","author":"D\u00f6nmez","year":"2013","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2026.106053_bib0235","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3109\/13506129.2011.574354078","article-title":"Do inflammatory rheumatic diseases still cause as much harm through amyloidosis?","volume":"18","author":"Hunter","year":"2011","journal-title":"Amyloid"},{"key":"10.1016\/j.jbspin.2026.106053_bib0240","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/13506129.2017.1342235","article-title":"Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre","volume":"24","author":"Lane","year":"2017","journal-title":"Amyloid"},{"key":"10.1016\/j.jbspin.2026.106053_bib0245","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/annrheumdis-2024-eular.2310","article-title":"OP0323 causes of AA amyloidosis: analysis of 952 patients seen at a reference centre over 34 years","volume":"83","author":"Lachmann","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106053_bib0250","doi-asserted-by":"crossref","first-page":"152762","DOI":"10.1016\/j.semarthrit.2025.152762","article-title":"AA amyloidosis in inflammatory joint diseases: A systematic review","volume":"74","author":"Savadogo","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106053_bib0255","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106053_bib0260","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/annrheumdis-2014-207151","article-title":"Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis","volume":"74","author":"Poddubnyy","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106053_bib0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106053_bib0270","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: Development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106053_bib0275","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2026.106053_bib0280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106053_bib0285","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.jbspin.2026.106053_bib0290","unstructured":"Loi no\u00a078-17 du 6 janvier 1978 relative \u00e0 l\u2019informatique, aux fichiers et aux libert\u00e9s. https:\/\/www.legifrance.gouv.fr\/loda\/id\/JORFTEXT000000886460\/. n.d."},{"key":"10.1016\/j.jbspin.2026.106053_bib0295","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/rheumatology\/kead465","article-title":"Characteristics and course of patients with AA amyloidosis: single centre experience with 174 patients from Turkey","volume":"63","author":"Bektas","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2026.106053_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/13506129.2014.980942","article-title":"Risk factors for AA amyloidosis in Germany","volume":"22","author":"Blank","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.jbspin.2026.106053_bib0305","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/nur.22262","article-title":"International migration and its influence on health","volume":"45","author":"Squires","year":"2022","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.jbspin.2026.106053_bib0310","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12992-024-01075-3","article-title":"Assessing the health status of migrants upon arrival in Europe: a systematic review of the adverse impact of migration journeys","volume":"20","author":"Canova","year":"2024","journal-title":"Global Health"},{"key":"10.1016\/j.jbspin.2026.106053_bib0315","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/acr.22542","article-title":"Association of socioeconomic status with treatment delays, disease activity, joint damage, and disability in rheumatoid arthritis","volume":"67","author":"Molina","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2026.106053_bib0320","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/acr.25264","article-title":"Factors associated with diagnostic delay in axial spondyloarthritis: impact of clinical factors and social vulnerability","volume":"76","author":"McDermott","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2026.106053_bib0325","doi-asserted-by":"crossref","first-page":"w13580","DOI":"10.4414\/smw.2012.13580","article-title":"AA amyloidosis: basic knowledge, unmet needs and future treatments","volume":"142","author":"Obici","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.jbspin.2026.106053_bib0330","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2026.106053_bib0335","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10067-010-1469-4","article-title":"Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis","volume":"29","author":"Nakamura","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2026.106053_bib0340","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.3899\/jrheum.090101","article-title":"Effective anti-TNF-\u03b1 therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis","volume":"36","author":"Kuroda","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2026.106053_bib0345","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.2169\/internalmedicine.55.6941","article-title":"Effects of biologic agents in patients with rheumatoid arthritis and amyloidosis treated with hemodialysis","volume":"55","author":"Kuroda","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.jbspin.2026.106053_bib0350","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjmed.2005.01.028","article-title":"Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists","volume":"118","author":"Fern\u00e1ndez-Nebro","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.jbspin.2026.106053_bib0355","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.11163","article-title":"Anti-tumor necrosis factor \u03b1 therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: A followup report of tolerability and efficacy","volume":"48","author":"Gottenberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106053_bib0360","doi-asserted-by":"crossref","DOI":"10.1136\/ard-2023-225114","article-title":"bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease","author":"Kvacskay","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2026.106053_bib0365","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/13506129.2014.1002031","article-title":"AA amyloidosis treated with tocilizumab: case series and updated literature review","volume":"22","author":"Courties","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.jbspin.2026.106053_bib0370","doi-asserted-by":"crossref","first-page":"c214","DOI":"10.1159\/000235241","article-title":"Cohort studies: prospective versus retrospective","volume":"113","author":"Euser","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jbspin.2026.106053_bib0375","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.revmed.2022.12.004","article-title":"French practical guidelines for the diagnosis and management of AA amyloidosis","volume":"44","author":"Georgin-Lavialle","year":"2023","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jbspin.2026.106053_bib0380","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/13506129.2018.1429391","article-title":"Obesity is a significant susceptibility factor for idiopathic AA amyloidosis","volume":"25","author":"Blank","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.jbspin.2026.106053_bib0385","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/art.1780391016","article-title":"High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis","volume":"39","author":"Hasegawa","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2026.106053_bib0390","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/1529-0131(200106)44:6<1266::AID-ART218>3.0.CO;2-3","article-title":"A novel single-nucleotide polymorphism at the 5\u2019-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis","volume":"44","author":"Moriguchi","year":"2001","journal-title":"Arthritis Rheum"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26000229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X26000229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:46:16Z","timestamp":1782917176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X26000229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1297319X26000229"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106053","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AA amyloidosis in inflammatory joint diseases in the era of biological therapies: Prevalence, manifestations, management and evolution","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2026.106053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106053"}}